Researchers have identified a potential new target for immunotherapy in pancreatic cancer, involving the sugar coating that tumors use to disguise themselves. This discovery may allow for the development of antibodies that can unmask pancreatic tumors, enabling the immune system to recognize and attack them. A new antibody has been found to wake the immune system against pancreatic cancer, although details of its application and effectiveness are not specified.